MYL6 and chronic kidney disease: The proteomic analysis of an advanced chronic kidney disease (CKD) cohort identified that proteins SPTA1, MYL6 and C6, when used alongside the 4-variable UK-KFRE, achieve an improved performance when predicting a 5-year risk of ESRD.